• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[中国2019新型冠状病毒病(COVID-19)疫情的流行病学特征]

[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].

机构信息

Chinese Center for Disease Control and Prevention, Beijing 102206, China.

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.

DOI:10.3760/cma.j.issn.0254-6450.2020.02.003
PMID:32064853
Abstract

An outbreak of 2019 novel coronavirus diseases (COVID-19) in Wuhan, China has spread quickly nationwide. Here, we report results of a descriptive, exploratory analysis of all cases diagnosed as of February 11, 2020. All COVID-19 cases reported through February 11, 2020 were extracted from China's Infectious Disease Information System. Analyses included: 1) summary of patient characteristics; 2) examination of age distributions and sex ratios; 3) calculation of case fatality and mortality rates; 4) geo-temporal analysis of viral spread; 5) epidemiological curve construction; and 6) subgroup analysis. A total of 72 314 patient records-44 672 (61.8) confirmed cases, 16 186 (22.4) suspected cases, 10567 (14.6) clinical diagnosed cases (Hubei only), and 889 asymptomatic cases (1.2)-contributed data for the analysis. Among confirmed cases, most were aged 30-79 years (86.6), diagnosed in Hubei (74.7), and considered mild/mild pneumonia (80.9). A total of 1 023 deaths occurred among confirmed cases for an overall case-fatality rate of 2.3. The COVID-19 spread outward from Hubei sometime after December 2019 and by February 11, 2020, 1 386 counties across all 31 provinces were affected. The epidemic curve of onset of symptoms peaked in January 23-26, then began to decline leading up to February 11. A total of 1 716 health workers have become infected and 5 have died (0.3). The COVID-19 epidemic has spread very quickly. It only took 30 days to expand from Hubei to the rest of Mainland China. With many people returning from a long holiday, China needs to prepare for the possible rebound of the epidemic.

摘要

中国武汉爆发的2019新型冠状病毒病(COVID-19)已迅速蔓延至全国。在此,我们报告截至2020年2月11日所有确诊病例的描述性探索性分析结果。2020年2月11日前报告的所有COVID-19病例均从中国传染病信息系统中提取。分析内容包括:1)患者特征总结;2)年龄分布和性别比检查;3)病死率和死亡率计算;4)病毒传播的地理时间分析;5)流行病学曲线构建;6)亚组分析。共有72314份患者记录——44672例(61.8%)确诊病例、16186例(22.4%)疑似病例、10567例(14.6%)临床诊断病例(仅湖北)和889例无症状病例(1.2%)——为分析提供了数据。在确诊病例中,大多数年龄在30至79岁之间(86.6%),在湖北确诊(74.7%),且被判定为轻症/轻度肺炎(80.9%)。确诊病例中共有1023例死亡,总体病死率为2.3%。COVID-19于2019年12月后的某个时间从湖北向外传播,到2020年2月11日,全国31个省份的1386个县受到影响。症状出现的流行曲线在1月23日至26日达到峰值,然后在2月11日前开始下降。共有1716名医护人员感染,5人死亡(0.3%)。COVID-19疫情传播非常迅速。从湖北蔓延至中国大陆其他地区仅用了30天时间。随着众多人员结束长假返程,中国需要为疫情可能的反弹做好准备。

相似文献

1
[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].[中国2019新型冠状病毒病(COVID-19)疫情的流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.
2
Data-based analysis, modelling and forecasting of the COVID-19 outbreak.基于数据的 COVID-19 疫情分析、建模和预测。
PLoS One. 2020 Mar 31;15(3):e0230405. doi: 10.1371/journal.pone.0230405. eCollection 2020.
3
Lockdown Contained the Spread of 2019 Novel Coronavirus Disease in Huangshi City, China: Early Epidemiological Findings. lockdown 限制措施遏制了 2019 年新型冠状病毒病在中国黄石市的传播:早期流行病学调查结果。
Clin Infect Dis. 2020 Sep 12;71(6):1454-1460. doi: 10.1093/cid/ciaa390.
4
[An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)].[新型冠状病毒肺炎(COVID-19)流行病学特征的最新情况]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):139-144. doi: 10.3760/cma.j.issn.0254-6450.2020.02.002.
5
Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.估算 2020 年 1-2 月中国新冠肺炎死亡风险。
Emerg Infect Dis. 2020 Jun;26(6):1251-1256. doi: 10.3201/eid2606.200233. Epub 2020 Jun 17.
6
Correlation between the migration scale index and the number of new confirmed coronavirus disease 2019 cases in China.中国新型冠状病毒病新增确诊病例数与迁移规模指数的相关性。
Epidemiol Infect. 2020 May 19;148:e99. doi: 10.1017/S0950268820001119.
7
The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.初步筛查和诊断的意义:中国湖南 33 例 SARS-CoV-2 感染轻症患者的临床特征。
J Clin Virol. 2020 Jul;128:104397. doi: 10.1016/j.jcv.2020.104397. Epub 2020 Apr 30.
8
Epidemiological Characteristics and Incubation Period of 7015 Confirmed Cases With Coronavirus Disease 2019 Outside Hubei Province in China.中国湖北省外 7015 例新型冠状病毒病确诊病例的流行病学特征和潜伏期。
J Infect Dis. 2020 Jun 16;222(1):26-33. doi: 10.1093/infdis/jiaa211.
9
Importance of timely management of patients in reducing fatality rate of coronavirus disease 2019.及时对患者进行管理对降低 2019 年冠状病毒病死亡率的重要性。
J Infect Public Health. 2020 Jun;13(6):890-892. doi: 10.1016/j.jiph.2020.04.015. Epub 2020 May 11.
10
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.中国甘肃省2019冠状病毒病的临床特征
Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.

引用本文的文献

1
Prevalence of common respiratory viruses in children: insights from post-pandemic surveillance.儿童常见呼吸道病毒的流行情况:大流行后监测的见解
BMC Infect Dis. 2025 Jul 1;25(1):824. doi: 10.1186/s12879-025-11201-0.
2
Immune profiles of a COVID-19 adolescent with mild symptoms and anti-viral antibody deficiency.一名患有轻度症状和抗病毒抗体缺乏症的新冠病毒病青少年的免疫特征。
Fundam Res. 2021 Mar;1(2):117-123. doi: 10.1016/j.fmre.2021.02.004. Epub 2021 Feb 17.
3
Risk Factors Affecting the Severity, Mortality, and Intensive Care Unit Admission of COVID-19 Patients: A Series of 1075 Cases.
影响新型冠状病毒肺炎患者严重程度、死亡率及入住重症监护病房的危险因素:1075例系列病例研究
Viruses. 2025 Mar 17;17(3):429. doi: 10.3390/v17030429.
4
Spatial analysis of COVID-19 incidence and mortality rates in northwest iran for future epidemic preparedness.伊朗西北部COVID-19发病率和死亡率的空间分析,以做好未来疫情防范准备。
Sci Rep. 2025 Mar 3;15(1):7450. doi: 10.1038/s41598-025-91246-y.
5
Progress in research on osteoporosis secondary to SARS-CoV-2 infection.新型冠状病毒肺炎继发骨质疏松症的研究进展
Animal Model Exp Med. 2025 May;8(5):829-841. doi: 10.1002/ame2.12573. Epub 2025 Mar 3.
6
Osteonecrosis following Steroid Therapy in COVID-19 Patients: An Outlook on the Emerging Problem.新冠病毒感染患者接受类固醇治疗后的骨坏死:对这一新兴问题的展望
Hip Pelvis. 2025 Mar 1;37(1):26-37. doi: 10.5371/hp.2025.37.1.26.
7
Efficacy of Telerehabilitation Protocols for Improving Functionality in Post-COVID-19 Patients.远程康复方案对改善新冠后患者功能的疗效
Life (Basel). 2025 Jan 1;15(1):44. doi: 10.3390/life15010044.
8
Consequences of COVID-19 for geriatric patients during a pandemic.新冠疫情期间COVID-19对老年患者的影响。
Sci Rep. 2025 Jan 24;15(1):3136. doi: 10.1038/s41598-024-84379-z.
9
COVID-19: A threat to the respiratory system.新型冠状病毒肺炎:对呼吸系统的一种威胁。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241310307. doi: 10.1177/03946320241310307.
10
Association of plasma microRNAs with COVID-19 severity and outcome.血浆微小RNA与COVID-19严重程度及预后的关联。
J Genet Eng Biotechnol. 2024 Dec;22(4):100433. doi: 10.1016/j.jgeb.2024.100433. Epub 2024 Nov 14.